Health knowledge and news provided by doctors.

Ads by Google

Prostate Cancer Treatment and Symptoms

Questions about prostate cancer therapies targeting IGF-1

Therapies under development for prostate cancer treatment by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results especially if a major tumor suppressor gene - p53 - is already compromised.

Biomarker predicts malignancy potential in prostate

Men whose prostate cancer screenings show high grade prostatic intraepithelial neoplasia (HG-PIN) may find themselves in limbo, 'stuck' between diagnoses - they are told prostate cancer has not yet developed, but it might, and they are advised to undergo repeated needle biopsies as a precaution.

Henry Ford Hospital expands prostate cancer treatment research

Henry Ford Hospital is embarking on an expanded major clinical trial involving the use of gene therapy in combination with radiation therapy, to determine if the combined treatment for prostate cancer is more effective than radiation therapy alone for patients with intermediate risk prostate cancer.

Men Can Take Their Time To Decide On Prostate Cancer Treatment

Is it safe to wait to make a decision about having prostate cancer surgery, even after you've waited and waited for all the doctor appointments and test results? Or will the additional delay reduce your chances of being cured? Reassuring research says that men can take the time they need to make their decisions, reports the February 2008 issue of Harvard Men's Health Watch.

Combination Of AVODART, Tamsulosin Provides Greater Benefit In Prostate Cancer Patients

Men with enlarged prostates who took a combination of AVODART, tamsulosin experienced significantly greater improvement in urinary symptoms than men prescribed either medication alone.

Common Molecule Notifies Immune System Of Prostate Cancer

In experiments with mice, researchers have found that the body's immune system can use a surprisingly common molecule to recognize prostate tumors. The molecule comes from a protein found in all cells of the body; however, immune cells appear to respond to it only when it is present on the surface of cells within a tumor.